Oracle is ditching a contentious plan to construct a natural gas plant to power one of its newest data centers. Instead, Oracle said last week that it will partner with fuel-cell maker Bloom Energy to ...
Oracle Corp. and its partners, building the huge Project Jupiter data center complex in the Santa Teresa, New Mexico, area, have dumped their initial power plan in favor of a new one that they promise ...
OpenAI and Oracle’s data center project in southern New Mexico will be powered by fuel cells rather than natural gas turbines and diesel generators, a move they say “dramatically reduces water use” ...
Hunt for Cylons, jump in a Viper, and get ready to go back to Caprica. The world of Battlestar Galactica is returning to streaming. After disappearing for about a year, all four seasons of the modern ...
If you have binoculars, you may even spot some of Jupiter’s largest moons as tiny pinpoints beside the planet NICHOLAS KAMM/AFP via Getty A waxing crescent moon and Jupiter will appear close together ...
On Wednesday evening (April 22), assuming your skies are reasonably clear, you can finish your day by stepping outside and enjoying a view of a rendezvous of two of the brightest objects in the night ...
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Jupiter Neurosciences, Inc.
A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested – and thus could not prove – whether the products were sterile. These ...
The Lower Rio Grande Basin is parched, with Elephant Butte Lake just 13% full after a bleak winter with little snowfall. So, how will a hyperscale data center project in Southern New Mexico find the ...
More than 3.1 million bottles of eye drops sold at major retailers, including Walgreens and CVS, are being recalled due to concerns about their sterility, according to a notice from the Food and Drug ...
Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
March 30 (Reuters) - Viridian Therapeutics (VRDN.O), opens new tab shares slumped 34% to an eight-month low on Monday after its experimental treatment for thyroid eye disease lagged ‌rivals in ...